Compare LION & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LION | CAI |
|---|---|---|
| Founded | 1997 | 2008 |
| Country | Canada | United States |
| Employees | N/A | 1846 |
| Industry | Movies/Entertainment | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.7B |
| IPO Year | 2025 | N/A |
| Metric | LION | CAI |
|---|---|---|
| Price | $16.07 | $18.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $11.89 | ★ $30.91 |
| AVG Volume (30 Days) | ★ 3.1M | 2.5M |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,631,800,000.00 | N/A |
| Revenue This Year | N/A | $25.24 |
| Revenue Next Year | $22.98 | $22.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $14.19 |
| 52 Week High | $16.70 | $42.50 |
| Indicator | LION | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 68.43 | 58.78 |
| Support Level | $13.19 | $17.21 |
| Resistance Level | $16.70 | $19.79 |
| Average True Range (ATR) | 0.66 | 1.09 |
| MACD | 0.09 | 0.18 |
| Stochastic Oscillator | 82.40 | 69.45 |
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.